Abbott Laboratories (ABT) CEO Miles White on Q2 2019 Results - Earnings Call Transcript

Abbott Laboratories (NYSE:ABT) Q2 2019 Results Conference Call July 17, 2019 9:00 AM ET

Company Participants

Scott Leinenweber - VP, IR, Licensing and Acquisitions
Miles White - Chairman and CEO
Robert Ford - President and COO
Brian Yoor - EVP, Finance and CFO

Conference Call Participants

David Lewis - Morgan Stanley
Robbie Marcus - JP Morgan
Bob Hopkins - Bank of America
Kristen Stewart - Barclays
Joanne Wuensch - BMO Capital Markets
Matthew Taylor - UBS

Operator

Good morning and thank you for standing by. Welcome to Abbott’s Second Quarter 2019 Earnings Conference Call. All participants will be able to listen only until the question-and-answer portion of this call. [Operator Instructions] This call is being recorded by Abbott. With the exception of any participant’s questions asked during the question-and-answer session, the entire call including the question-and-answer session is material copyrighted by Abbott. It cannot be recorded or rebroadcast without Abbott’s express written permission.

I would now like to introduce Mr. Scott Leinenweber, Vice President, Investor Relations, Licensing and Acquisitions.

Scott Leinenweber

Good morning and thank you for joining us. With me today are Miles White, Chairman of the Board and Chief Executive Officer; Robert Ford, President and Chief Operating Officer; and Brian Yoor, Executive Vice President, Finance and Chief Financial Officer. Miles will provide opening remarks and Brian will discuss our performance and outlook in more detail. Following their comments, we’ll take your questions.

Before we get started, some statements made today may be forward-looking for purposes of the Private Securities Litigation Reform Act of 1995, including the expected financial results for 2019. Abbott cautions that these forward-looking statements are subject to the risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements.

Economic, competitive, governmental, technological and other factors that may affect Abbott’s operations